Prenatal Diagnostics: Invasive testing, nonin
Explore all reports for “Diagnostics� market @ http://www.lifescienceindustryresearch.com/category/diagn .
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising mater
New to Insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development. Report Highlights: • Exclusive interviews with CEOs, CSOs, and Vice Presidents from Sequenom, Verinata Health, Ariosa Diagnostics, Natera, Silicon Biosystems, Metabolomic
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising mater
• Diagnostics and NX PharmaGen • Specifications of particular instruments • Company goals, customer feedback, challenges encountered, competitive advantage, platform pricing, and future endeavors. • A survey capturing the demographics of the prenatal industry is presented at the end of the report, specifically highlighting organizational background, areas of research, challenges encountered, and applications in development. • Directory of companies within Prenatal Diagnostics
Complete report is available @ http:// www.lifescienceindustryresearch.com/prenatal-diagnostics-invasive-testing-noninvasive-testing-and-risi .
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising mater
Executive Summary New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare. Although covering standard invasive procedure, this report focuses on the noninvasive technologies either on the market or in development. Request Discount @ http://www.lifescienceindustryresearch.com/discount?rname=13195 .
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising mater
The first chapter of this report discusses microarray-based cytogenetics and how it compares to karyotyping. Karyotyping is often the standard method used to detect chromosomal aneuploidies, but with microarray-based procedures even more aneuploidies can be detected with the same efficacy. Either method can be used in sync with noninvasive procedures that show positive screening results for aneuploidies, but microarray analysis may be more useful for copy number variations that often go undetected with karyotyping. Request Discount @ http://www.lifescienceindustryresearch.com/discount?rname=13195 .
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising mater
Highlighting noninvasive methods, several companies have come out with novel technologies that allow them to analyze fetal DNA without risk of injury to the mother or fetus. Amniocentesis and chorionic villus sampling are common methods used to analyze fetal DNA for aneuploidies but at the risk of miscarriage and infection. With noninvasive procedures, screening can be done for common aneuploidies and further analysis can be done on women with only positive results
Complete report is available @ http:// www.lifescienceindustryresearch.com/prenatal-diagnostics-invasive-testing-noninvasive-testing-and-risi .
About lifescienceindustryresearch.com lifescienceindustr yresearch.com  is your single source for all market research needs. Our database includes 250,000+ syndicated market research reports from 100+ leading global publishers covering in-depth analysis of over 5000 micro markets. With comprehensive information about the publishers and their report methodology, data sources, etc. we help you in your purchase decision by mapping your information needs with the most relevant available reports in our library.
Connect with us: sales@lifescienceindustryresearch.com + 1 888 391 5441 Contact: http://www.lifescienceindustryresearch.com for further Contact: sales@reportsandreports.com for further information. information.